This action by the NYSE results from the fact that the company has now fallen below the NYSE’s continued listing minimum share price standard as the average closing price of its common stock is less than $1.00 over a consecutive 30 trading day period. The company has acknowledged that it would not be possible to affirm an intent to cure this deficiency within the Exchange's prescribed timeframes. In addition, the company announced on September 14, 2005 that it and certain of its U.S. subsidiaries have filed voluntary petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of New York. The NYSE noted that it may, at any time, suspend a security if it believes that continued dealings in the security on the NYSE are not advisable. The other securities include the following repackaged issues: Lehman ABS Corporation Corporate Backed Trust Certificates, Series 2001-19, Class A-1 due December 15, 2029 – ticker symbol CDC – and the Lehman ABS Corporation Corporate Backed Trust Certificates, Series 2001-6, due December 15, 2029 – ticker symbol CYA.
Company contact: See Section 802.00 of the NYSE Listed Company Manual for continued listing criteria and procedure for delisting |